These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37929699)

  • 1. Decoding the molecular interplay in the central dogma: An overview of mass spectrometry-based methods to investigate protein-metabolite interactions.
    Stincone P; Naimi A; Saviola AJ; Reher R; Petras D
    Proteomics; 2024 Jun; 24(12-13):e2200533. PubMed ID: 37929699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted and proteome-wide analysis of metabolite-protein interactions.
    Tsukidate T; Li Q; Hang HC
    Curr Opin Chem Biol; 2020 Feb; 54():19-27. PubMed ID: 31790852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry methods to study protein-metabolite interactions.
    Guo H; Peng H; Emili A
    Expert Opin Drug Discov; 2017 Dec; 12(12):1271-1280. PubMed ID: 28933205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoproteomic profiling of protein-metabolite interactions.
    Qin W; Yang F; Wang C
    Curr Opin Chem Biol; 2020 Feb; 54():28-36. PubMed ID: 31812894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging.
    Lee DY; Bowen BP; Northen TR
    Biotechniques; 2010 Aug; 49(2):557-65. PubMed ID: 20701590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatially Resolved Mass Spectrometry at the Single Cell: Recent Innovations in Proteomics and Metabolomics.
    Taylor MJ; Lukowski JK; Anderton CR
    J Am Soc Mass Spectrom; 2021 Apr; 32(4):872-894. PubMed ID: 33656885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of organ-on-a-Chip samples for mass spectrometry based proteomics and metabolomics via Dansylation-based assay.
    Gallagher EM; Rizzo GM; Dorsey R; Dhummakupt ES; Moran TS; Mach PM; Jenkins CC
    Toxicol In Vitro; 2023 Apr; 88():105540. PubMed ID: 36563973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mass spectrometric insight into the origins of benign gynecological disorders.
    Yang H; Lau WB; Lau B; Xuan Y; Zhou S; Zhao L; Luo Z; Lin Q; Ren N; Zhao X; Wei Y
    Mass Spectrom Rev; 2017 May; 36(3):450-470. PubMed ID: 26633258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Knowns and Unknowns in Protein-Metabolite Interactions.
    Kurbatov I; Dolgalev G; Arzumanian V; Kiseleva O; Poverennaya E
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics and proteomics technologies to explore the herbal preparation affecting metabolic disorders using high resolution mass spectrometry.
    Zhang A; Zhou X; Zhao H; Zou S; Ma CW; Liu Q; Sun H; Liu L; Wang X
    Mol Biosyst; 2017 Jan; 13(2):320-329. PubMed ID: 28045158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry in systems biology: an overview.
    Feng X; Liu X; Luo Q; Liu BF
    Mass Spectrom Rev; 2008; 27(6):635-60. PubMed ID: 18636545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution mass spectrometry based techniques at the crossroads of metabolic pathways.
    Junot C; Fenaille F; Colsch B; Bécher F
    Mass Spectrom Rev; 2014; 33(6):471-500. PubMed ID: 24288070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Map of Protein-Metabolite Interactions Reveals Principles of Chemical Communication.
    Piazza I; Kochanowski K; Cappelletti V; Fuhrer T; Noor E; Sauer U; Picotti P
    Cell; 2018 Jan; 172(1-2):358-372.e23. PubMed ID: 29307493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell mass spectrometry.
    Tajik M; Baharfar M; Donald WA
    Trends Biotechnol; 2022 Nov; 40(11):1374-1392. PubMed ID: 35562238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in quantitative mass spectrometry for the analysis of proteome dynamics.
    Hughes C; Krijgsveld J
    Trends Biotechnol; 2012 Dec; 30(12):668-76. PubMed ID: 23107010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential blood biomarkers for stroke.
    Laborde CM; Mourino-Alvarez L; Akerstrom F; Padial LR; Vivanco F; Gil-Dones F; Barderas MG
    Expert Rev Proteomics; 2012 Aug; 9(4):437-49. PubMed ID: 22967080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of technologies for MS-based proteomics-centric multi-omics.
    Rajczewski AT; Jagtap PD; Griffin TJ
    Expert Rev Proteomics; 2022 Mar; 19(3):165-181. PubMed ID: 35466851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry-based metabolomics for an in-depth questioning of human health.
    Alves S; Paris A; Rathahao-Paris E
    Adv Clin Chem; 2020; 99():147-191. PubMed ID: 32951636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics Work Flow and Analytics in Systems Biology.
    Chacko S; Haseeb YB; Haseeb S
    Curr Mol Med; 2022; 22(10):870-881. PubMed ID: 34923941
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.